AEMD News and Press, Aethlon Medical Inc.

2024-06-28 12:40:00 ET SAN DIEGO - June 28, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. ( Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal ye...

2024-06-27 18:37:05 ET Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Conference Call June 27, 2024, 04:30 PM ET Company Participants Michael Miller - Rx Communications, IR James Frakes - Interim CEO and CFO Steven LaRosa - Chief Medical Officer Conference C...

2024-06-27 16:18:35 ET More on Aethlon Medical Aethlon Medical FY 2024 Earnings Preview Aethlon Medical announces pricing of $4.7 million public offering Seeking Alpha’s Quant Rating on Aethlon Medical Historical earnings data for Aethlon Medical ...

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update PR Newswire Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO , June 27, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Na...

DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024 PR Newswire SAN DIEGO , June 21, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to ...

2024-06-20 10:30:00 ET June 20, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform, releases an industry snapshot looking at the future treatment of solid cancer tumors, featuring Aethlon Medical, Inc. (Nasdaq:AEMD ), a medical therapeutic company f...

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 20, 2024) - Investorideas.com , a go-to investing platform, releases an industry snapshot looking at the future treatment of solid cancer tumors, featuring Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic compan...

2024-06-18 10:50:00 ET SAN DIEGO - June 18, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. ( Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that, on June, 13, 2024, the Human...

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial PR Newswire Aethlon Medical Granted Full Ethics Approval From the Human Research Ethics Committee at Central Adelaide Local Health Network for a Safety, Feasibility, and Dose Finding Study o...